Category: Regulatory

May 18, 2022

The Department of Health and Human Services (HHS) (@HHSGov) awarded $16.3 million in grant funding to support 31 grantees to enhance and expand the telehealth infrastructure and capacity of Title X family planning clinics in 26 states, one U.S. territory, […]

May 17, 2022

A collection of 24 states is throwing its support to the federal government in a legal fight with several drugmakers over access to drugs discounted under the 340B program. The states and the District of Columbia announced in legal filings […]

May 13, 2022

New legislation in the House and Senate aims to increase the role of health equity in the development of value-based payment models, including a demand that the Biden administration create a model specifically on dual-eligible beneficiaries, behavioral health and maternal […]

May 6, 2022

Once viewed as a convenient, one-dose alternative to the multi-shot regimens from Pfizer and Moderna, J&J’s shot has instead been marred by safety concerns that have curtailed its use in the U.S. and elsewhere. Even before the vaccine was launched […]

April 25, 2022

Democratic lawmakers and advocacy groups are making a push to convince the Biden administration to nix a controversial Trump-era rule that expanded the duration of short-term health plans. A collection of more than 40 House Democrats wrote to Department Health […]

April 25, 2022

The Trump administration in last January approved a decadelong extension of Texas’ Medicaid waiver, just days before President Joe Biden was sworn into office. The state applied for ane tension early, as the waiver was scheduled to expire in fall […]

April 21, 2022

Officials said that the Department of Justice is filing an appeal aiming to overturn a federal judge’s ruling that struck down the federal mask mandate on public transportation. A notice of appeal was filed Wednesday in federal court in Tampa, […]

April 12, 2022

Given enough time and energy, the body will heal, but when doctors or engineers intervene, the processes do not always proceed as planned because chemicals that control and facilitate the healing process are missing. Now, an international team of engineers […]

April 12, 2022

A bipartisan group of lawmakers wants a bipartisan bill to lower insulin prices to also outlaw drug rebates for the key diabetes treatment. The collection of bipartisan House and Senate lawmakers released a list of top policy priorities for limiting […]

April 7, 2022

New bipartisan legislation introduced in the House aims to reform Medicaid to enable the use of value-based purchasing agreements in Medicaid. The Medicaid VBP Act, released Tuesday, aims to ensure new treatments such as gene therapies would be administered under […]

April 6, 2022

President Joe Biden has ordered the Department of Health and Human Services (HHS) to strengthen care for individuals experiencing “long COVID” and increase clinical research on prolonged illness and other conditions following an acute COVID-19 infection. Tuesday’s memorandum instructs HHS […]

April 5, 2022

The Senate has reached a bipartisan deal for $10 billion in COVID-19 relief that does not fully replenish funds for providers to get reimbursement for uninsured claims. Senate Majority Leader Chuck Schumer announced the deal Tuesday, but it does not […]

March 29, 2022

With the Supreme Court expected to overturn or severely weaken its landmark Roe v. Wade decision, clinics in Colorado are preparing for an increase in the number of out-of-state residents seeking abortions, and lawmakers are cementing abortion access protections in […]

March 28, 2022

The US Food and Drug Administration (FDA) has granted 510(k) clearance for the marketing of Sky Medical Technology’s new (W3) geko device variant. The new device has been designed to increase microcirculatory blood flow in lower limb soft tissue in […]

March 21, 2022

Will Medicare drug price negotiation quash innovation of new drugs, or allow innovation to continue while also saving seniors from having to stop taking needed medicines or cut their pills in half? That was the focus of a Senate Finance […]